Cardiology overview electrophysiology: Difference between revisions
Jump to navigation
Jump to search
| Line 2: | Line 2: | ||
{{CMG}} | {{CMG}} | ||
==Implantable Cardiac Defibrillator== | ==STEMI and Arrhythmias== | ||
===Implantable Cardiac Defibrillator=== | |||
* Should not be implanted within 40 days of STEMI | * Should not be implanted within 40 days of STEMI | ||
* [[Amiodarone]] improves CV survival but not all cause survival in patients with an LVEF of <40% | |||
==Atrial Fibrillation== | ==Atrial Fibrillation== | ||
Revision as of 16:04, 31 October 2011
|
Cardiology Overview |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
STEMI and Arrhythmias
Implantable Cardiac Defibrillator
- Should not be implanted within 40 days of STEMI
- Amiodarone improves CV survival but not all cause survival in patients with an LVEF of <40%
Atrial Fibrillation
Rate Control vs Rhythm Control
- Rhythm control offers no benefit over rate control in survival
- Rate control is very important in preventing the tachycardia cardiomyopathy syndrome